Call Us: 02380 97 07 33

Posts Tagged ALTITUDE

Safety Update: ALTITUDE ‘unboost’

Safety Update: ALTITUDE ‘unboost’

by Kazeem Olalekan MRPharmS Early result from the ALiskiren Trial In Type 2 diabetes Using cardiovascular and renal Disease Endpoints (ALTITUDE) study has shown that: study patients were unlikely to benefit from aliskiren; and an increased incidence of non-fatal strokes, renal complications (including acute renal failure), hyperkalaemia […]

Read more


The information on this site is provided 'as is' Whilst we stake our reputation on producing the most accurate information (and employ reasonable care and skill in providing this site's content), we cannot warrant that the information is accurate, complete and up to date. Neither can we guarantee uninterrupted performance and durability.
Click here to read our complete terms and conditions.